Bullish option flow detected in Apellis Pharmaceuticals with 4,272 calls trading, 3x expected, and implied vol increasing over 6 points to 70.62%. May-23 85 calls and May-23 95 calls are the most active options, with total volume in those strikes near 3,100 contracts. The Put/Call Ratio is 0.06. Earnings are expected on May 3rd.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on APLS:
- Apellis presents Phase 3 functional analyses of SYFOVRE for geographic atrophy
- Apellis Presents Phase 3 Functional Analyses of SYFOVRE™ (pegcetacoplan injection) for Geographic Atrophy
- Apellis Pharmaceuticals call volume above normal and directionally bullish
- Apellis announces validation for four marketing applications for pegcetacoplan
- Apellis Announces Validation of Four Marketing Applications for Pegcetacoplan for Geographic Atrophy